Treatment intensification for patients with type 2 diabetes and poor glycaemic control

DOES CLINICAL INERTIA VARY BY PERSONALIZED A1C GOAL? A STUDY OF PREDICTORS AND PREVALENCE OF CLINICAL INERTIA IN A U.S. MANAGED-CARE SETTING

(2016) Jay Lin et al.   Endocrine Practice

Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes

(2015) Sanjoy K Paul et al.   Cardiovascular Diabetology

Comparative effectiveness of early versus delayed metformin in the treatment of type 2 diabetes

(2015) Robert J. Romanelli et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015

(2015) Alan J. Garber et al.   Endocrine Practice

AACE Comprehensive Diabetes Management Algorithm 2013

(2015) Alan Garber et al.   Endocrine Practice

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2014) Silvio E. Inzucchi et al.   DIABETES CARE

Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy

(2014) Swapnil N. Rajpathak et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study

(2014) Marsha A. Raebel et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy

(2011) A. Z. Fu et al.   DIABETES OBESITY & METABOLISM

Potential drug interactions associated with treatments for Type 2 diabetes and its comorbidities: a clinical pharmacology review

(2011) Jeffrey S Freeman et al.   Expert Review of Clinical Pharmacology